Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V

Molecular Biology of the Cell

Volumn 23, Issue 13, 2012, Pages 2571-2582

  Schmees, C ^a,c   Villasenor R ^b   Zheng, W ^a,d   Ma, H ^a   Zerial, M ^b   Heldin, C H ^a   Hellberg, Carina ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN TYROSINE KINASE; RAB PROTEIN; RABANKYRIN 5; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; HUMAN; HUMAN CELL; ONCOGENE H RAS; PINOCYTOSIS; PRIORITY JOURNAL; TUMOR GROWTH;

CELL ADHESION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; HUMANS; MUTATION, MISSENSE; PHOSPHORYLATION; PINOCYTOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-SIS; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSPORT VESICLES;

EID: 84863535725     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-04-0317     Document Type: Article

References (57)

1. Amyere M, Payrastre B, Krause U, Van Der Smissen P, Veithen A, Courtoy PJ (2000). Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C. Mol Biol Cell 11, 3453-3467.
2. Andrae J, Gallini R, Betsholtz C (2008). Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22, 1276-1312. (Pubitemid 351717519)
3. Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL (1991). Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci USA 88, 10435-10439. (Pubitemid 21915850)
4. Bache KG, Slagsvold T, Stenmark H (2004). Defective downregulation of receptor tyrosine kinases in cancer. EMBO J 23, 2707-2712. (Pubitemid 39013543)
5. Bao J, Alroy I, Waterman H, Schejter ED, Brodie C, Gruenberg J, Yarden Y (2000). Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome. J Biol Chem 275, 26178-26186.
6. Bar-Sagi D, Feramisco JR (1986). Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233, 1061-1068. (Pubitemid 16032234)
7. Burden-Gulley SM, Brady-Kalnay SM (1999). PTPmu regulates N-cadherin-dependent neurite outgrowth. J Cell Biol 144, 1323-1336. (Pubitemid 29157308)
8. Calzolari F, Malatesta P (2010). Recent insights into PDGF-induced gliomagenesis. Brain Pathol 20, 527-538.
9. Carnero A (2010). The PKB/AKT pathway in cancer. Curr Pharmaceut Des 16, 34-44.
10. Chen KT, Lin JD, Liou MJ, Weng HF, Chang CA, Chan EC (2006). An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines. Cancer Lett 231, 192-205. (Pubitemid 43038730)
11. Chiara F, Goumans MJ, Forsberg H, Ahgren A, Rasola A, Aspenstrom P, Wernstedt C, Hellberg C, Heldin CH, Heuchel R (2004). A gain of function mutation in the activation loop of platelet-derived growth factor beta-receptor deregulates its kinase activity. J Biol Chem 279, 42516-42527. (Pubitemid 39372135)
12. Davies PF, Ross R (1978). Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor. J Cell Biol 79, 663-671. (Pubitemid 9079933)
13. Disanza A, Frittoli E, Palamidessi A, Scita G (2009). Endocytosis and spatial restriction of cell signaling. Mol Oncol 3, 280-296.
14. Downward J (2003). Targeting RAS signalling pathways in cancer therapy. Nat Rev 3, 11-22.
15. Eyster CA, Higginson JD, Huebner R, Porat-Shliom N, Weigert R, Wu WW, Shen RF, Donaldson JG (2009). Discovery of new cargo proteins that enter cells through clathrin-independent endocytosis. Traffic 10, 590-599.
16. Fischer AN, Fuchs E, Mikula M, Huber H, Beug H, Mikulits W (2007). PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene 26, 3395-3405. (Pubitemid 46788880)
17. Frederick L, Wang XY, Eley G, James CD (2000). Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res 60, 1383-1387. (Pubitemid 30152011)
18. Gotzmann J et al. (2006). A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene 25, 3170-3185. (Pubitemid 43881558)
19. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999). Creation of human tumour cells with defined genetic elements. Nature 400, 464-468. (Pubitemid 29361801)
20. Hellberg C, Schmees C, Karlsson S, Ahgren A, Heldin CH (2009). Activation of protein kinase C alpha is necessary for sorting the PDGF beta-receptor to Rab4a-dependent recycling. Mol Biol Cell 20, 2856-2863.
21. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M (1992). Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52, 3213-3219.
22. Hewlett LJ, Prescott AR, Watts C (1994). The coated pit and macropinocytic pathways serve distinct endosome populations. J Cell Biol 124, 689-703. (Pubitemid 24085779)
23. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P, Donovan M, Cordon-Cardo C, Beug H, Grunert S (2006). Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 116, 1561-1570.
24. Jiang BH, Liu LZ (2009). PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102, 19-65.
25. Karlsson S, Kowanetz K, Sandin A, Persson C, Ostman A, Heldin CH, Hellberg C (2006). Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) beta-receptor but not the PDGF alpha-receptor. Mol Biol Cell 17, 4846-4855. (Pubitemid 44665753)
26. Karnoub AE, Weinberg RA (2008). Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9, 517-531. (Pubitemid 351881844)
27. Kerr MC, Lindsay MR, Luetterforst R, Hamilton N, Simpson F, Parton RG, Gleeson PA, Teasdale RD (2006). Visualisation of macropinosome maturation by the recruitment of sorting nexins. J Cell Sci 119, 3967-3980. (Pubitemid 44650870)
28. Kerr MC, Teasdale RD (2009). Defining macropinocytosis. Traffic 10, 364-371.
29. Kholodenko BN (2006). Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7, 165-176.
30. Koumakpayi IH, Le Page C, Delvoye N, Saad F, Mes-Masson AM (2011). Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells. Mol Carcinog 50, 901-912.
31. Levkowitz G, Waterman H, Zamir E, Kam Z, Oved S, Langdon WY, Beguinot L, Geiger B, Yarden Y (1998). c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev 12, 3663-3674. (Pubitemid 29019647)
32. Martinez-Lacaci I, Kannan S, De Santis M, Bianco C, Kim N, Wallace-Jones B, Ebert AD, Wechselberger C, Salomon DS (2000). RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. Int J Cancer 88, 44-52.
33. Mayor S, Pagano RE (2007). Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8, 603-612. (Pubitemid 47106613)
34. Mitchell H, Choudhury A, Pagano RE, Leof EB (2004). Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11. Mol Biol Cell 15, 4166-4178. (Pubitemid 39122020)
35. Mitin N, Rossman KL, Der CJ (2005). Signaling interplay in Ras superfamily function. Curr Biol 15, R563-574. (Pubitemid 41026614)
36. Mosesson Y, Mills GB, Yarden Y (2008). Derailed endocytosis: an emerging feature of cancer. Nat Rev 8, 835-850.
37. Muller PA et al. (2009). Mutant p53 drives invasion by promoting integrin recycling. Cell 139, 1327-1341.
38. Murphy JE, Padilla BE, Hasdemir B, Cottrell GS, Bunnett NW (2009). Endosomes: a legitimate platform for the signaling train. Proc Natl Acad Sci USA 106, 17615-17622.
39. Persson C et al. (2004a). Site-selective regulation of platelet-derived growth factor beta receptor tyrosine phosphorylation by T-cell protein tyrosine phosphatase. Mol Cell Biol 24, 2190-2201. (Pubitemid 38248956)
40. Persson C, Sjoblom T, Groen A, Kappert K, Engstrom U, Hellman U, Heldin CH, den Hertog J, Ostman A (2004b). Preferential oxidation of the second phosphatase domain of receptor-like PTP-alpha revealed by an antibody against oxidized protein tyrosine phosphatases. Proc Natl Acad Sci USA 101, 1886-1891. (Pubitemid 38228986)
41. Peschard P, Park M (2003). Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell 3, 519-523. (Pubitemid 36808646)
42. Petiot A, Faure J, Stenmark H, Gruenberg J (2003). PI3P signaling regulates receptor sorting but not transport in the endosomal pathway. J Cell Biol 162, 971-979. (Pubitemid 37174182)
43. Porat-Shliom N, Kloog Y, Donaldson JG (2008). A unique platform for H-Ras signaling involving clathrin-independent endocytosis. Mol Biol Cell 19, 765-775. (Pubitemid 351481795)
44. Reynolds AR, Tischer C, Verveer PJ, Rocks O, Bastiaens PI (2003). EGFR activation coupled to inhibition of tyrosine phosphatases causes lateral signal propagation. Nat Cell Biol 5, 447-453. (Pubitemid 36592268)
45. Rink J, Ghigo E, Kalaidzidis Y, Zerial M (2005). Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735-749. (Pubitemid 41242638)
46. Rodahl LM, Stuffers S, Lobert VH, Stenmark H (2009). The role of ESCRT proteins in attenuation of cell signalling. Biochem Soc Trans 37, 137-142.
47. Roepstorff K, Grovdal L, Grandal M, Lerdrup M, van Deurs B (2008). Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer. Histochem Cell Biol 129, 563-578.
48. Rönnstrand L, Terracio L, Claesson-Welsh L, Heldin CH, Rubin K (1988). Characterization of two monoclonal antibodies reactive with the external domain of the platelet-derived growth factor receptor. J Biol Chem 263, 10429-10435.
49. Sadowski L, Pilecka I, Miaczynska M (2009). Signaling from endosomes: location makes a difference. Exp Cell Res 315, 1601-1609.
50. Schnatwinkel C, Christoforidis S, Lindsay MR, Uttenweiler-Joseph S, Wilm M, Parton RG, Zerial M (2004). The Rab5 effector Rabankyrin-5 regulates and coordinates different endocytic mechanisms. PLoS Biol 2, E261.
51. Shin HW et al. (2005). An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway. J Cell Biol 170, 607-618.
52. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182. (Pubitemid 17231334)
53. Swanson JA, Watts C (1995). Macropinocytosis. Trends Cell Biol 5, 424-428.
54. Toffalini F, Hellberg C, Demoulin JB (2010)Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein. J Biol Chem 285, 12268-12278.
55. Tonks NK (2005). Redox redux: revisiting PTPs and the control of cell signaling. Cell 121, 667-670.
56. West MA, Bretscher MS, Watts C (1989). Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells. J Cell Biol 109, 2731-2739. (Pubitemid 20011900)
57. Zwick E, Bange J, Ullrich A (2001). Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 8, 161-173. (Pubitemid 32947638)